18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden.

MLA

Sheng, Ling-Shuang, et al. “18F-FDG PET/CT Metrics-Based Stratification of Large B-Cell Lymphoma Receiving CAR-T Cell Therapy: Immunosuppressive Tumor Microenvironment as a Negative Prognostic Indicator in Patients with High Tumor Burden.” Biomarker Research, vol. 12, no. 1, Sept. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s40364-024-00650-5.

APA

Sheng, L.-S., Shen, R., Yan, Z.-X., Wang, C., Zheng, X., Zhang, Y.-L., Yang, H.-X., Wu, W., Xu, P.-P., Cheng, S., Bachy, E., Sesques, P., Jacquet-Francillon, N., Jiang, X.-F., Zhao, W.-L., & Wang, L. (2024). 18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden. Biomarker Research, 12(1), 1–7. https://doi.org/10.1186/s40364-024-00650-5

Chicago

Sheng, Ling-Shuang, Rong Shen, Zi-Xun Yan, Chao Wang, Xin Zheng, Yi-Lun Zhang, Hao-Xu Yang, et al. 2024. “18F-FDG PET/CT Metrics-Based Stratification of Large B-Cell Lymphoma Receiving CAR-T Cell Therapy: Immunosuppressive Tumor Microenvironment as a Negative Prognostic Indicator in Patients with High Tumor Burden.” Biomarker Research 12 (1): 1–7. doi:10.1186/s40364-024-00650-5.